How Does DT1 Sphere Perform in Current and Successful Acuvue MAX Wearers?
NCT ID: NCT06847230
Last Updated: 2025-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2024-07-15
2024-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Soft Lens Study: Biomedics 1 Day Extra Sphere and Clariti 1 Day Sphere
NCT06817785
A Clinical Comparison of Two Soft Toric Contact Lenses
NCT06758089
Performance of Wearers of Stenfilcon A Contact Lenses After A Refit With Test Lenses
NCT03496701
Refitting Somofilcon A Sphere Contact Lens Wearers Into Fanfilcon A Sphere Lenses for 4-Weeks of Wear
NCT03974802
Evaluation of Lens Rotation in Habitual Wearers of Toric, Soft Contact Lenses
NCT06649019
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dailies total 1 contact lenses
Acuvue max wearers will be refit into dailies total 1
Dailies total 1 contact lenses
successful refit into dt1 will be determined
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dailies total 1 contact lenses
successful refit into dt1 will be determined
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants will be required to have worn Oasys MAX 1-day CLs for at least 3 months in the past year and currently wearing these CLs.
* All participants will be required to have a CLDEQ-8 score \<12 while wearing their habitual CLs (Oasys MAX 1-days) and to indicate that they are satisfied with Oasys MAX 1-day CLs (Yes/No).
* Participants will be required to be able to wear DT1 Sphere CLs (astigmatism \< 0.75D OD/OS).
* Participants will be required to wear the study CLs for ≥12 hours with no overnight wear
* Participants will be required to use digital devices at least 8 hours/day.
* Participants will be required to provide a glasses prescription that is less than 3 years old.
Exclusion Criteria
* Have worn DT1 in the past for more than 1 week.
* Are past rigid CL wearers.
* Have a history of being diagnosed with dry eye or ocular allergies.
* Have known systemic health conditions that are thought to alter tear film physiology.
* Have corrected acuity 1 line or more worse vision recorded at Visit 2 (compared to the Visit 1 findings) with their optimized Oasys MAX 1-day lenses.
* Have a history of viral eye disease.
* Have a history of ocular surgery.
* Have a history of severe ocular trauma.
* Have a history of corneal dystrophies or degenerations.
* Have active ocular infection or inflammation.
* Are currently using isotretinoin-derivatives or ocular medications.
* Are pregnant or breast feeding
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Southern College of Optometry
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Southern College of Optometry
Memphis, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-07-01CL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.